InterBioMed
Public support
Provider
Ministry of Education, Youth and Sports
Programme
National Programme for Sustainability I
Call for proposals
Národní program udržitelnosti 2 (SMSM2014LO2)
Main participants
Ústav organické chemie a biochemie AV ČR, v. v. i.
Contest type
VS - Public tender
Contract ID
MSMT-7778/2014
Alternative language
Project name in Czech
InterBioMed
Annotation in Czech
Cílem projektu je studovat molekulární mechanismy interakcí patogenů s jejich hostiteli, porozumět regulaci nádorového bujení a vyvíjet nové typy léků umožňujících účinnou regulaci těchto mechanismů
Scientific branches
R&D category
ZV - Basic research
CEP classification - main branch
CE - Biochemistry
CEP - secondary branch
EB - Genetics and molecular biology
CEP - another secondary branch
EE - Microbiology, virology
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10606 - Microbiology<br>10607 - Virology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>30101 - Human genetics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Research of the InterBioMed centre LO 1302 NPU I was focused on viral, bacterial, and tumor diseases, and development of novel types of medications. It was carried out in collaboration with national and international research institutions and companies. 52 FTE research and technical workers and national and international students, including 30 new student positions, were supported from this project. The research results were published in more than 100 publications in a number of prestigious journals. In addition, 58 results were solely obtained by InterBioMed members. Our results are also part of 9 international and 2 national awarded patents. This project enabled a stable financing of our reseach and contributed to development of new molecular approaches for study of different diseases and their treatment.
Solution timeline
Realization period - beginning
Jul 1, 2014
Realization period - end
Jun 30, 2019
Project status
U - Finished project
Latest support payment
Feb 4, 2019
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP20-MSM-LO-U/01:1
Data delivery date
Jun 4, 2020
Finance
Total approved costs
233,180 thou. CZK
Public financial support
116,590 thou. CZK
Other public sources
69,954 thou. CZK
Non public and foreign sources
46,636 thou. CZK